Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

AVXL

Anavex Life Sciences (AVXL)

Anavex Life Sciences Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AVXL
DateTimeSourceHeadlineSymbolCompany
10/31/20243:00AMGlobeNewswire Inc.Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024NASDAQ:AVXLAnavex Life Sciences Corporation
10/23/20247:03AMInvestorsHub NewsWireZenaTech, Inc. (NASDAQ: ZENA) Software Company AcquisitionNASDAQ:AVXLAnavex Life Sciences Corporation
10/17/20246:30AMGlobeNewswire Inc.Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of SchizophreniaNASDAQ:AVXLAnavex Life Sciences Corporation
10/15/20247:21AMInvestorsHub NewsWireZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory ManagementNASDAQ:AVXLAnavex Life Sciences Corporation
10/01/20246:00AMInvestorsHub NewsWireZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading TodayNASDAQ:AVXLAnavex Life Sciences Corporation
09/03/20246:30AMGlobeNewswire Inc.Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024NASDAQ:AVXLAnavex Life Sciences Corporation
08/06/20244:21PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVXLAnavex Life Sciences Corporation
08/06/20246:30AMGlobeNewswire Inc.Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business UpdateNASDAQ:AVXLAnavex Life Sciences Corporation
08/01/20246:30AMGlobeNewswire Inc.Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024NASDAQ:AVXLAnavex Life Sciences Corporation
07/30/20244:20PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVXLAnavex Life Sciences Corporation
07/30/20246:30AMGlobeNewswire Inc.Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
07/29/20244:21PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:AVXLAnavex Life Sciences Corporation
07/28/20244:00PMGlobeNewswire Inc.Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
06/20/20246:30AMGlobeNewswire Inc.Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
06/17/20246:30AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
05/22/20246:30AMGlobeNewswire Inc.Anavex Life Sciences Announces Expansion of Leadership TeamNASDAQ:AVXLAnavex Life Sciences Corporation
05/17/20245:01AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
05/17/20245:01AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
05/14/20246:30AMGlobeNewswire Inc.Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQNASDAQ:AVXLAnavex Life Sciences Corporation
05/10/20244:45AMPR Newswire (US)Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:AVXLAnavex Life Sciences Corporation
05/09/20243:35PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVXLAnavex Life Sciences Corporation
05/09/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVXLAnavex Life Sciences Corporation
05/09/20246:30AMGlobeNewswire Inc.Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business UpdateNASDAQ:AVXLAnavex Life Sciences Corporation
05/07/20244:45AMPR Newswire (US)The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) ShareholdersNASDAQ:AVXLAnavex Life Sciences Corporation
05/06/20245:03AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AVXLAnavex Life Sciences Corporation
05/03/20244:45AMPR Newswire (US)Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
05/02/20246:30AMGlobeNewswire Inc.Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024NASDAQ:AVXLAnavex Life Sciences Corporation
04/26/20244:45AMPR Newswire (US)May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
04/19/20244:45AMPR Newswire (US)Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL)NASDAQ:AVXLAnavex Life Sciences Corporation
04/16/20244:45AMPR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
 Showing the most relevant articles for your search:NASDAQ:AVXL

Your Recent History

Delayed Upgrade Clock